Estimating the burden of healthcare-associated infections caused by selected multidrug-resistant bacteria Finland, 2010

Antimicrobial Resistance and Infection Control

Mari Kanerva²  Jukka Ollgren³  Antti J Hakanen¹  Outi Lyytikäinen³ 

[1] Unit of Antimicrobial Resistance, Department of Infectious Disease Surveillance and Contro, National Institute for Health and Welfare (THL), P.O. Box 57, FI-20521, Turku, Finland

[2] Helsinki University Central Hospital, Department of Medicine, Division of Infectious Diseases, POB 348, FIN-00029, HUS, FINLAND

[3] Epidemiologic Surveillance and Control Unit, Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare (THL), P.O. Box 30, FI-00271, Helsinki, Finland

关键词: Resource allocation;    Infection control;    Burden of HAI;    Healthcare-associated infections;    Multidrug-resistant microbes;   

Others  :  791088
DOI  :  10.1186/2047-2994-1-33

 received in 2012-05-28, accepted in 2012-10-01,  发布年份 2012

【 摘 要 】

Background

Knowledge of the burden of healthcare-associated infections (HAI) and antibiotic resistance is important for resource allocation in infection control. Although national surveillance networks do not routinely cover all HAIs due to multidrug-resistant bacteria, estimates are nevertheless possible: in the EU, 25,000 patients die from such infections annually. We assessed the burden of HAIs due to multidrug-resistant bacteria in Finland in 2010.

Methods

By combining data from the National Infectious Disease Registry on the numbers of bacteremias caused by Staphylococcus aureus, Enterococcus faecium, Escherichia coli, Klebsiella pneumoniae, Enterobacter spp., Pseudomonas aeruginosa and Acinetobacter spp., and susceptibility data from the National Antimicrobial Resistance Network and the Finnish Hospital Infection Program, we assessed the numbers of healthcare-associated bacteremias due to selected multidrug-resistant bacteria. We estimated the number of pneumonias, surgical site and urinary tract infections by applying the ratio of these infections in the first national prevalence survey for HAI in 2005. Attributable HAI mortality (3.2%) was also derived from the prevalence survey.

Results

The estimated annual number of the most common HAIs due to the selected multidrug-resistant bacteria was 2804 (530 HAIs per million), 6% of all HAIs in Finnish acute care hospitals. The number of attributable deaths was 89 (18 per million).

Conclusions

Resources for infection control should be allocated not only in screening and isolation of carriers of multidrug-resistant bacteria, even when they are causing a small proportion of all HAIs, but also in preventing all clinical infections.

【 授权许可】

   
2012 Kanerva et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]European Centre for Disease Prevention and Control ECDC/ European Medicines Agency: EMEA Joint Technical Report: The bacterial challenge: time to react. ECDC, Stockholm Sweden; 2009. Available from: http://www.ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf webcite
• [2]European Centre for Disease Prevention and Control (ECDC): Annual Epidemiological Report on Communicable Diseases in Europe 2008. ECDC, Stockholm Sweden; 2008. Available from: http://www.ecdc.europa.eu/en/publications/Publications/0812_SUR_Annual_Epidemiological_Report_2008.pdf webcite
• [3]Kanerva M, Ollgren J, Virtanen MJ, Lyytikäinen O: Prevalence Survey Study Group. Estimating the annual burden of health care-associated infections in Finnish adult acute care hospitals. Am J Infection Control 2009, 7:227-30.
• [4]Lyytikäinen O, Kanerva M, Agthe N, Möttönen T, Ruutu P: Finnish Prevalence Survey Study Group. Healthcare-associated infections in Finnish acute care hospitals: a national prevalence survey, 2005. J Hosp Infect 2008, 69:288-294.
• [5]Infectious Diseases in Finland: Annual Report of National Infectious Disease Registry. In Edited by Hulkko T, Lyytikäinen O, Jaakola S, Kuusi M, Puumala J, Ruutu P. 2010. http://www.thl.fi/thl-client/pdfs/1d73f597-8188-4ff5-b33c-101d7e1c3e90 webcite
• [6]Lyytikäinen O, Klements P, Ruutu P, et al.: Defining the population-based burden of nosocomial pneumococcal bacteremia. Arch Intern Med 2007, 167:1635-40.
• [7]Rice LB: Federal funding for the study of antimicrobial resistance in nosocmial pathogens: no ESKAPE. Infect Control Hospital Epidemiol 2008, 197:1079-81.
• [8]Driex L, Brossier F, Duquesnoy O, et al.: Increase in hospital-acquired bloodstream infections caused by extended spectrum β-lactamase-producing Escherichia coli in a large French teaching hospital. Eur J Clin Microbiol Infect Dis 2009, 28:491-8.
• [9]Tumbarello M, Sali M, Trecarichi EM, et al.: Bloodstream infections caused by extended-sprectrum-b-lactamase-producing Escherichia coli: Risk factrs for inadequated intitial antimicrobial therapy. Antimicr Agents Chemother 2008, 52:3244-52.
• [10]Forssten SD, Kolho E, Lauhio A, et al.: Emergence of extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella pneumoniae during the years 2000–2004 in Helsinki, Finland. CMI 2010, 16:1155-71.
• [11]Rodriques-Bano J, Navarro MD, Romero L, et al.: Bacteremia due to Extended-spactrum b-lactamase-producing Escherichia coli in the CTX-M era: anew clinical challenge. CID 2006, 43:1407-14.
• [12]Pitout JDD, Gregson DB, Campbell L, Lauland KB: Molecular characteristics of extended-spectrum-b-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clones ST131 as a cause of community-acquired infections. Antimicr Agents and Chemotherapy 2009, 53:2846-51.
• [13]Kanerva M, Salmenlinna S, Vuopio-Varkila J, et al.: Community-associated methicillin-resistant Staphylococcus aureus isolated in Finland in 2004 to 2006. J Clin Microbiol 2009, 47:2655-7.
• [14]Wenzel R, Bearman G, Edmond M: Screening for MRSA: a flawed hospital infection control intervention. Infect Control Hosp Epidemiol 2008, 29:1012-1018.
• [15]Wenzel RP, Edmond MB: Infection control: the case for horizontal rather than vertical interventional programs. Int J Infect Dis 2010, 14(S4):S3-S5.